iOmx Therapeutics’ €65 Million Series B Financing Round

GÖRG Partnerschaft von Rechtsanwälten mbB advised MIG Capital AG on the deal, while Alles & Overy advised iOmx Therapeutics.iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here